{
    "2020-03-31": [
        [
            {
                "time": "2020-03-31",
                "original_text": "泰格医药(300347.SZ)：附属方达控股2019年归母净利升63.90%至1842.4万美元",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "方达控股",
                        "归母净利",
                        "增长",
                        "63.90%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-31",
                "original_text": "民生医药|事件点评：泰格医药：子公司业绩良性增长，符合预期",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "子公司",
                        "业绩增长",
                        "符合预期"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}